Widespread Image Manipulation Uncovered in Commercial Laboratory Antibody Supply Data

A comprehensive scientific audit has uncovered widespread image manipulation across promotional data and validation documentation published by commercial laboratory antibody suppliers. Forensic analysis revealed duplicated gel bands, digital splicing, and altered contrast levels in Western blot figures used to prove antibody specificity.

Researchers caution that unvalidated or mislabeled commercial antibodies cause massive financial waste and irreproducible experimental results across oncology, neuroscience, and immunology studies worldwide.

In response to the audit, academic journals and institutional oversight boards are demanding stringent third-party verification protocols and raw, unedited image file submissions from chemical supply vendors.